The rise of Sildenafil initially fueled a surge for major pharmaceutical companies, but recent developments present a murky picture for shareholders. Off-patent competitors are reducing revenue, and continued patent https://brianyenp227315.blogzag.com/84553779/viagra-and-the-pharmaceutical-industry-a-precarious-play